Showing results (1271-1280 of 2,904) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|August 17, 2013
Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2Y A Aldhamen, S S Seregin, Y A Kousa, et al.Cancer Gene Therapy|September 21, 2013
Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumorsJ K Y Chan, P Y P LamCancer Gene Therapy|September 21, 2013
Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responsesY Xie, Y Chen, K A Ahmed, et al.Cancer Gene Therapy|June 15, 2013
Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by TiazofurinP Kusumanchi, Y Zhang, M B Jani, et al.Cancer Gene Therapy|June 15, 2013
Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancerT J Johnson, N Höti, C Liu, et al.Cancer Gene Therapy|July 6, 2013
The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virusK Fujii, K Kurozumi, T Ichikawa, et al.Cancer Gene Therapy|May 11, 2013
Inhibitors of C5 complement enhance vaccinia virus oncolysisD Magge, Z S Guo, M E O'Malley, et al.Cancer Gene Therapy|March 30, 2013
Transfection of Kasumi-1 cells with a new type of polymer carriers loaded with miR-155 and antago-miR-155O V Klimenko, M I ShtilmanCancer Gene Therapy|April 27, 2013
Oncolytic bovine herpesvirus type 1 infects and kills breast tumor cells and breast cancer-initiating cells irrespective of tumor subtypeB P Cuddington, A L Dyer, S T Workenhe, et al.Cancer Gene Therapy|April 27, 2013
The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapyY-F Huang, M-J Chen, M-H Wu, et al.Pageof 291